Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Recommendations for the management of patients with immune-mediated kidney disease during the severe acute respiratory syndrome coronavirus 2 pandemic

Anders, Hans Joachim ; Bruchfeld, Annette ; Fernandez Juarez, Gema Maria ; Floege, Jürgen ; Goumenos, Dimitrios ; Turkmen, Kultigin ; Van Kooten, Cees ; Tesar, Vladimir and Segelmark, Mårten LU (2020) In Nephrology Dialysis Transplantation 35(6). p.920-925
Abstract

The coronavirus disease 2019 (COVID-19) pandemic has created major challenges for all countries around the globe. Retrospective studies have identified hypertension, cardiovascular disease, diabetes and older age as risk factors for high morbidity and mortality from COVID-19. There is a general concern that patients with immune-mediated kidney diseases, namely those on immunosuppressive therapies and/or those with more advanced kidney failure, could particularly be at risk for adverse outcomes due to a compromised antiviral immunity. Uncertainties exist on how management routines should be reorganized to minimize the risk of severe acute respiratory syndrome coronavirus 2 infection and what measures are necessary for infected patients.... (More)

The coronavirus disease 2019 (COVID-19) pandemic has created major challenges for all countries around the globe. Retrospective studies have identified hypertension, cardiovascular disease, diabetes and older age as risk factors for high morbidity and mortality from COVID-19. There is a general concern that patients with immune-mediated kidney diseases, namely those on immunosuppressive therapies and/or those with more advanced kidney failure, could particularly be at risk for adverse outcomes due to a compromised antiviral immunity. Uncertainties exist on how management routines should be reorganized to minimize the risk of severe acute respiratory syndrome coronavirus 2 infection and what measures are necessary for infected patients. The aim of the present review of the Immunonephrology Working Group of the European Renal Association-European Dialysis and Transplant Association is to provide recommendations for the management of patients with immune-mediated kidney diseases based on the available evidence, similar circumstances with other infectious organisms and expert opinions from across Europe. Such recommendations may help to minimize the risk of encountering COVID-19 or developing complications during COVID-19 in patients with immune-mediated kidney disease.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
COVID-19, glomerulonephritis, lupus, renal vasculitis, steroids
in
Nephrology Dialysis Transplantation
volume
35
issue
6
pages
6 pages
publisher
Oxford University Press
external identifiers
  • pmid:32445573
  • scopus:85086346128
ISSN
0931-0509
DOI
10.1093/ndt/gfaa112
language
English
LU publication?
yes
id
adea3c51-c5e9-4796-8462-e2269d4f6812
date added to LUP
2021-01-04 14:32:29
date last changed
2024-05-16 00:41:14
@article{adea3c51-c5e9-4796-8462-e2269d4f6812,
  abstract     = {{<p>The coronavirus disease 2019 (COVID-19) pandemic has created major challenges for all countries around the globe. Retrospective studies have identified hypertension, cardiovascular disease, diabetes and older age as risk factors for high morbidity and mortality from COVID-19. There is a general concern that patients with immune-mediated kidney diseases, namely those on immunosuppressive therapies and/or those with more advanced kidney failure, could particularly be at risk for adverse outcomes due to a compromised antiviral immunity. Uncertainties exist on how management routines should be reorganized to minimize the risk of severe acute respiratory syndrome coronavirus 2 infection and what measures are necessary for infected patients. The aim of the present review of the Immunonephrology Working Group of the European Renal Association-European Dialysis and Transplant Association is to provide recommendations for the management of patients with immune-mediated kidney diseases based on the available evidence, similar circumstances with other infectious organisms and expert opinions from across Europe. Such recommendations may help to minimize the risk of encountering COVID-19 or developing complications during COVID-19 in patients with immune-mediated kidney disease.</p>}},
  author       = {{Anders, Hans Joachim and Bruchfeld, Annette and Fernandez Juarez, Gema Maria and Floege, Jürgen and Goumenos, Dimitrios and Turkmen, Kultigin and Van Kooten, Cees and Tesar, Vladimir and Segelmark, Mårten}},
  issn         = {{0931-0509}},
  keywords     = {{COVID-19; glomerulonephritis; lupus; renal vasculitis; steroids}},
  language     = {{eng}},
  number       = {{6}},
  pages        = {{920--925}},
  publisher    = {{Oxford University Press}},
  series       = {{Nephrology Dialysis Transplantation}},
  title        = {{Recommendations for the management of patients with immune-mediated kidney disease during the severe acute respiratory syndrome coronavirus 2 pandemic}},
  url          = {{http://dx.doi.org/10.1093/ndt/gfaa112}},
  doi          = {{10.1093/ndt/gfaa112}},
  volume       = {{35}},
  year         = {{2020}},
}